Bellevue Group’s LB Pharmaceuticals LBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.5M Buy
+715,513
New +$29.6M 0.57% 43

Other funds holding LBRX

Bellevue Group's LBRX Position: Q3 2026 in Review

Bellevue Group opened a new position in LB Pharmaceuticals (LBRX) in Q3 2026: 715,513 shares worth $27.5M. The stake represents 0.57% of the portfolio and ranks #43 among its holdings.

147 funds tracked by Wall St. Rank hold LBRX as of Q3 2026.

  • Bellevue Group held 715,513 shares of LB Pharmaceuticals worth $27.5M as of Q3 2026.
  • LB Pharmaceuticals was a new Bellevue Group position in Q3 2026.
  • LB Pharmaceuticals made up 0.57% of Bellevue Group's portfolio in Q3 2026, its #43 holding.
  • 147 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q3 2026.

Based on Bellevue Group's 13F filing for Q3 2026, filed 16 Nov 2026.